Lasagna’s Law: Patient Recruitment and Clinical Trials

Effective recruitment of patients is one of the most important ingredients for a successful clinical trial. Yet, today, 11% of clinical research sites fail to enroll even a single participant, and nearly 90% of clinical trials experience significant delays due to issues with patient recruitment. Over 40 years after Dr Louis Lasagna came up with his law of progressively diminishing returns in patient recruitment, the problem still looms large for drug developers. This article by Cromos Pharma’s CEO, Vlad Bogin, explores the continuing relevance of “Lasagna’s Law” and looks at ways to address patient recruitment challenges. Read more: https://www.sciencedirect.com/science/article/pii/S2451865422000175

Cromos Pharma proudly supports the Right2hope nonprofit platform, empowering patients to explore treatment options beyond traditional clinical trials. Through an intuitive, AI-supported matching algorithm, Right2hope connects patients with the most relevant expanded access, compassionate use, and right-to-try programs.